Trial intelligence / Profile preview

Edaravone for Radiation-induced Temporal Lobe Necrosis

NCT01865201Phase 2Completed

Sponsor
Sun Yat-sen Memorial Hospital
Start
Mar 2009
Primary completion
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of edaravone in radiation necrosis (RN), sponsored by Sun Yat-sen Memorial Hospital. Started Mar 2009; status: completed.

02

Drugs

edaravone
03

Conditions

radiation necrosis (RN)

Beyond the preview

Go deeper on NCT01865201.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01865201.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call